The Ontario Government is excited about the new isotope production line at Bruce Power, which will double its capacity to produce the medical isotope lutetium-177. This expansion will help meet the rising demand for lutetium-177, used to treat various cancers, including prostate cancer and neuroendocrine tumours.
Premier Ford expressed enthusiasm, highlighting the benefits of nuclear power and its role in providing life-saving medical isotopes.
The second isotope production system, set to be completed by the end of 2024, is a collaboration between Bruce Power, the Saugeen Ojibway Nation, Isogen, and ITM. This follows the installation of the first system in 2022, which made Bruce Power the first commercial power reactor to produce lutetium-177.
Minister of Energy Todd Smith emphasized that Ontario’s nuclear reactors not only provide over 50% of the province’s electricity but also produce vital medical isotopes. He praised the government’s investment in nuclear energy for transforming healthcare.
The Saugeen Ojibway Nation leaders, who co-market the isotopes, also attended the event. Their partnership supports the global fight against cancer while creating economic opportunities in their territory.
As part of “Powering Ontario’s Growth,” the government is making significant investments in nuclear energy, including:
- Pre-development work at Bruce Power for the first large-scale nuclear build in over 30 years, potentially powering 4.8 million homes.
- Site preparation for four small modular reactors as part of the Darlington New Nuclear Project, potentially powering 1.2 million homes.
- Supporting the refurbishment of the Pickering Nuclear Generating Station, potentially powering 2 million homes.
This expansion reinforces Ontario’s leadership in producing cancer-fighting medical isotopes and its commitment to safe, reliable, and affordable energy.
Written by: K. Milhomens
